Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lolke de Haan

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Oncoimmunology|April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.
Regulatory Toxicology and Pharmacology : RTP|March 4, 2020
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluationHelen Prior, Paul Baldrick, Sonja Beken, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Oncoimmunology|April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.
Regulatory Toxicology and Pharmacology : RTP|March 4, 2020
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluationHelen Prior, Paul Baldrick, Sonja Beken, et al.
Pageof 3